Sumary of : Abbott Labs Q2 adj. EPS $1.17; FactSet consensus $1.02:
- Abbott Laboratories Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products.
- It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices.
- The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products.